Open Access
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases
Liping Liu, Weiqi Chen, Hongyu Zhou, Wanying Duan, Shujuan Li, Xiaochuan Huo, Weihai Xu, Li'an Huang, Huaguang Zheng, Jingyi Liu, Hui Liu, Yufei Wei, Jie Xu, Yongjun Wang
DOI: 10.1136/svn-2020-000378 Published 18 June 2020
Liping Liu
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Weiqi Chen
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Hongyu Zhou
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Wanying Duan
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Shujuan Li
2Department of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
Xiaochuan Huo
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Weihai Xu
3Department of Neurology, Peking Union Medical College Hospital, Beijing, China
Li'an Huang
4Department of Neurology, Guangzhou Overseas Chinese Hospital, The First Affiliated Hospital of JINAN University, Guangzhou, China
Huaguang Zheng
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Jingyi Liu
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Hui Liu
2Department of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
Yufei Wei
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Jie Xu
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Yongjun Wang
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

No eLetters have been published for this article.
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases
Liping Liu, Weiqi Chen, Hongyu Zhou, Wanying Duan, Shujuan Li, Xiaochuan Huo, Weihai Xu, Li'an Huang, Huaguang Zheng, Jingyi Liu, Hui Liu, Yufei Wei, Jie Xu, Yongjun Wang
Stroke and Vascular Neurology Jun 2020, svn-2020-000378; DOI: 10.1136/svn-2020-000378

Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases
Liping Liu, Weiqi Chen, Hongyu Zhou, Wanying Duan, Shujuan Li, Xiaochuan Huo, Weihai Xu, Li'an Huang, Huaguang Zheng, Jingyi Liu, Hui Liu, Yufei Wei, Jie Xu, Yongjun Wang
Stroke and Vascular Neurology Jun 2020, svn-2020-000378; DOI: 10.1136/svn-2020-000378
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases
Liping Liu, Weiqi Chen, Hongyu Zhou, Wanying Duan, Shujuan Li, Xiaochuan Huo, Weihai Xu, Li'an Huang, Huaguang Zheng, Jingyi Liu, Hui Liu, Yufei Wei, Jie Xu, Yongjun Wang
Stroke and Vascular Neurology Jun 2020, svn-2020-000378; DOI: 10.1136/svn-2020-000378
- Article
- Abstract
- Introduction
- Section 1: definitions associated with ischaemic cerebrovascular diseases
- Section 2: emergency assessment and diagnosis of patients with ischaemic stroke
- Section 3: reperfusion therapy for AIS
- Section 4: antiplatelet aggregation therapy for acute ischaemic cerebrovascular disease
- Section 5: other treatment in the acute phase
- Section 6: general supportive care and complications management
- Section 7: early evaluation and diagnosis of aetiology and pathogenesis of ischaemic cerebrovascular disease
- Section 8: intervention on aetiology and pathogenesis
- Section 9: management of risk factors and long-term intervention
- Footnotes
- References
- Figures & Data
- eLetters
- Info & Metrics